Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1862-3514
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland ; volume:16 ; number:1 ; day:17 ; month:4 ; year:2021 ; pages:1-11 ; date:12.2021
Archives of osteoporosis ; 16, Heft 1 (17.4.2021), 1-11, 12.2021
- Urheber
-
Walsh, Mary E.
Fahey, Tom
Moriarty, Frank
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11657-021-00932-7
- URN
-
urn:nbn:de:101:1-2021060511371398225009
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Walsh, Mary E.
- Fahey, Tom
- Moriarty, Frank
- SpringerLink (Online service)
Ähnliche Objekte (12)
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Medication-related osteonecrosis of the jaw : bisphosphonates, denosumab, and new agents
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?
Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Medication-related osteonecrosis of the jaw : bisphosphonates, denosumab, and new agents
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?
Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Medication-related osteonecrosis of the jaw : bisphosphonates, denosumab, and new agents
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?